Health Highlights: March 28, 2022

Stakes are high ahead of FDA panel vote on ALS drug. Advocacy groups are pressing the agency to fast-track approval of an experimental drug treatment for the deadly neurological disease. But are regulators moving too fast? Read more
Second COVID-19 vaccine boosters to be offered to Americans over 50. Optional second boosters of the Pfizer or Moderna vaccines could be authorized by the U.S. Food and Drug Administration as early as this week. But debate rages over the timing and effectiveness of such a move. Read more
Owners can play big role in dogs' problem behaviors. Nearly 1 in 3 pet dogs suffer from ADHD-like repetitive behaviors, and researchers now suspect that an animal's home life could be the cause. Read more
Hospitalization extremely rare for the vaccinated or those with prior COVID infection. A study of more than 100,000 American patients found their odds of winding up in the hospital following a 'breakthrough' infection was practically nil. Read more
Related Posts
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician's Briefing chose as the most important...
Want That Pill to Work Fast? Your Body Position Matters
WEDNESDAY, Aug. 17, 2022 (HealthDay News) -- If you need to take a pill, you...
Multidose BCG Protects Against COVID-19 in At-Risk Individuals
TUESDAY, Aug. 16, 2022 (HealthDay News) -- The multidose Bacillus...
How ‘This Is Us’ Put Alzheimer’s Care in the Spotlight
THURSDAY, Sept. 1, 2022 (HealthDay News) -- When the wildly popular TV show...
